A revised model of uncertainty in complex healthcare settings: a scoping review

C Pomare, K Churruca, LA Ellis… - Journal of evaluation …, 2019 - Wiley Online Library
Background Uncertainty is a ubiquitous and dynamic presence throughout healthcare
systems and encounters, affecting the quality and safety of care. Although previous research …

Interaction between physicians and the pharmaceutical industry: A scoping review for developing a policy brief

E Zarei, A Ghaffari, A Nikoobar, S Bastami… - Frontiers in Public …, 2023 - frontiersin.org
Background Payments to physicians by the pharmaceutical industry are common, but recent
evidence shows that these payments influence physician prescribing behavior in the form of …

The Dilemma of Compulsory Vaccinations—Ethical and Legal Considerations

Y Sela, K Grinberg, R Nissanholtz-Gannot - Healthcare, 2023 - mdpi.com
The high childhood vaccination coverage in Israel leads to a low rate of morbidity from the
diseases against which the vaccination in administered. However, during the COVID-19 …

[PDF][PDF] Attitudes and behaviours of physicians towards the relationship with the pharmaceutical industry in Saudi Arabia

S Bahammam, S Asiri, Y Al-Jahdali… - Eastern …, 2020 - vlibrary.emro.who.int
Background: The relationship and interactions between physicians and the pharmaceutical
industry can affect patient care. A physician's practice can be influenced by this relationship …

[HTML][HTML] Strategies for Management of Conflict of Interests in the Pharmaceutical Sector: A Systematic Review

EH Roknabadi, S Vatankhah, HA Gorji, M Behzadifar… - Health Scope, 2024 - brieflands.com
Context: Conflict of interest has always been one of the challenges facing healthcare
systems. The pharmaceutical sector is one of the main components of healthcare systems …

[HTML][HTML] Conflict of interest in physician–pharmaceutical industry interactions: Possible interventions in Nigeria medical practice

IV Ezeome - International Journal of Medicine and Health …, 2021 - journals.lww.com
Collaboration between physicians and the pharmaceutical, medical device, and
biotechnology industries results in the development of products of great benefit to the public …

Mapping the Donations of Pharma Companies in Greece: The Case of Scientific Societies

S Chatzivasileiou, A Emmanouil-Kalos… - … , S., Emmanouil-Kalos …, 2023 - papers.ssrn.com
Pharmaceutical companies are major donors to medical-related civil society organizations
worldwide, which has raised concerns about their influence on public health policy. The …

Bioética y la promoción de medicamentos

JMT Barros, A Zavala-Calahorrano… - ATENEO, 2021 - colegiomedicosazuay.ec
Antecedentes La Organización Mundial de la Salud (OMS) reconoce que la promoción de
medicamentos está convirtiéndose en un problema de salud pública, por lo que la ausencia …

Physicians' moral dilemmas in the age of Viagra

L Ayalon, A Gewirtz-Meydan - Men and masculinities, 2021 - journals.sagepub.com
Oral phosphodiesterase5 inhibitors (PDE5i; eg, Viagra®) have become the first line of
treatment of erectile dysfunction (ED) in men. Relying on interviews with 38 physicians, this …

[PDF][PDF] Caso: controversias bioéticas de las donaciones de las compañías farmacéuticas a los centros sanitarios

A González-González - Cuadernos de Bioética, 2020 - aebioetica.org
La interacción entre los médicos y las compañías farmacéuticas ha sido y es habitual, se
produce de múltiples formas y ha demostrado, en muchos casos, ser necesaria para el …